Reply: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention

MLA

Apurva A, Motivala, et al. “Reply: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention.” JACC. Cardiovascular Interventions, vol. 9, no. 23, Oct. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........ec00da5f09f0617ea80daf611744f1d9&authtype=sso&custid=ns315887.

APA

Apurva A, M., Valay, P., Matthew, R., David, D., J Dawn, A., Abhiram, P., & Debabrata, M. (2016). Reply: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention. JACC. Cardiovascular Interventions, 9(23).

Chicago

Apurva A, Motivala, Parikh Valay, Roe Matthew, Dai David, Abbott J Dawn, Prasad Abhiram, and Mukherjee Debabrata. 2016. “Reply: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention.” JACC. Cardiovascular Interventions 9 (23). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........ec00da5f09f0617ea80daf611744f1d9&authtype=sso&custid=ns315887.